At close: December 20 at 11:00:35 AM GMT+1
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in PLN.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Grzegorz Stefanski | President of the Management Board | -- | -- | -- |
| Mr. Tomasz Kostuch | Member of the Management Board | -- | -- | -- |
Urteste S.A.
ul. Starodworska 1
Gdansk, 80-137
Poland
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 28
Description
Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland.
Corporate Governance
Urteste S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
GRCE Grace Therapeutics, Inc.
3.8200
-5.91%
IMNN Imunon, Inc.
0.8300
-2.84%
LPCN Lipocine Inc.
4.8700
+4.06%
IBIO iBio, Inc.
2.4800
+2.48%
CMRX Chimerix, Inc.
2.9900
+4.91%
VRDN Viridian Therapeutics, Inc.
19.03
+1.60%
ADMA ADMA Biologics, Inc.
17.40
-2.79%
SGMT Sagimet Biosciences Inc.
4.9500
-2.37%
CKPT Checkpoint Therapeutics, Inc.
3.7500
+11.28%
RXRX Recursion Pharmaceuticals, Inc.
6.03
-0.99%